Sep 18, 2025
3 min read
Search shows that most patients can read additional lines on eye examination cards after treatment twice a day
Your doctor developed a special eye for people with a desire that can replace the need for a glass of reading or surgery.
Hundreds of millions of people around the world have Presbyopia, and that's when the eyes are difficult to concentrate on objects and text up close.Bar or surgery can usually solve the problem, but many find that they wear uncomfortable glasses and that traffic is not possible for everyone.
Now, experts say the solution can be as simple as using drops twice a day.
A study is presented in the European Union (Skar) in the European Union (Skar) in the European Union in the Copenagan on Sunday, which many people can read additional lines on test cards after using droples.The mother is supported for two years.
To wear glass or dislike or dislikes, it can be treated as obstacles or dislikes.
The drops contain pilocarpine, a drug that accumulates students and contributes to the muscle.
The study included 766 people in Argentina who used dots twice a day an hour and about six hours later.
It was divided into three parts, discovered various changes.At the end of Diklfiaaaaa, but a combination of traditional events is 1%.
In 148, by falling 1 %, almost everyone was able to read two or more lines in the chart.In the 2 % group, 69 % of 248 patients were able to read an additional line or more, and in the 3 % group, 84 % of 370 patients could read an additional line or more.
Dr. JOVANNA BENZZI, the director of the center at Buenos is the completion center of the 5.45 examination of the test. Treatment also improves interest in all distances.
"Provision of 99% of the Silocist patients received an accurate optimal vision and were able to read two or more other lines."
Reano offers the rude and effective and effective and well-made for a continuous designate, "the cometze was said.
The effects of the general side had a temporary dark vision, anger when the drops were managed and the headaches.
The experts welcome these findings and ask for more research. "A broader, long -term and multicenter research is needed to confirm security and effectiveness before this treatment can be highly recommended," said the elected president of Esc, Professor Burkhard Dick.
